Analytical Data
-
基因名
VF
- Application
-
别名
VF；C7orf9；RFRP；Pro-FMRFamide-related neuropeptide VF
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9HCQ7
-
表达区间
56-92aa
-
氨基酸序列
SLNFE ELKDWGPKNV IKMSTPAVNK MPHSFANLPL RF
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
VF recombinant proteins have gained significant attention in the fields of biotechnology and medicine due to their diverse applications and therapeutic potential. VF proteins are originally derived from various organisms, including bacteria, fungi, and plants, and are engineered to enhance their functional properties for specific purposes. The production of recombinant VF proteins enables researchers to study protein interactions, mechanisms of action, and disease pathways in a controlled environment. Moreover, these proteins are crucial in developing vaccines, diagnostic tools, and enzyme-based therapies. As advancements in genetic engineering, such as CRISPR and synthetic biology, continue to evolve, the ability to optimize VF proteins for improved efficacy and safety becomes increasingly feasible. The rising prevalence of infectious diseases, cancers, and metabolic disorders has further driven research toward the utilization of VF proteins for innovative treatment strategies. Current studies focus on the production efficiency, purification methods, structural characterization, and functional analysis of VF recombinant proteins, leading to promising developments in drug design and personalized medicine. These groundbreaking discoveries hold great potential for revolutionizing therapeutic approaches and addressing global health challenges.
